Given the activation of the BCR-ABL signaling pathway is critical for BCR-ABL to promote CML cell survival, we next measured CML cell apoptotic signals after P5091 treatment. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.